Pharmaceutical companies face growing debt costs, expiring patents, protracted development cycles and industry disruption. Fresh consideration of investment could reignite growth As 2025 approaches, ...
Bendell said, “I am honored and committed to fostering a culture of collaborative innovation as we look to gain increased traction in the U.S. market. Gelteq’s ingestible gel technology has the ...
Scientists are repurposing their research about bacteria-powered biobatteries into a new idea for artificial plants that can feed off carbon dioxide, give off oxygen and even generate a little power.
Gelteq Limited ("Gelteq" or the "Company"), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible ...
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel ...